Cidara Therapeutics (NASDAQ:CDTX – Get Free Report)‘s stock had its “overweight” rating restated by equities research analysts at Cantor Fitzgerald in a report issued on Monday, Marketbeat.com reports ...

Opportunistic fungal pathogens may cause superficial or serious invasive infections, especially in immunocompromised and debilitated patients. Invasive mycoses represent an exponentially growing ...

12 13 Corticosteroid doses were standardised using equivalent prednisolone dosing (pred-eq) and mould-active antifungal therapy was defined as any regimen containing voriconazole, isavuconazole, ...

Antifungal dietary supplements can aid in combating fungal infections within the body. Various factors, such as a compromised immune system, poor hygiene, and exposure to contaminated environments ...

The Manchester-based company said the new cash will help it to complete the late-stage development of olorofim, a novel oral antifungal for invasive aspergillosis and other serious fungal ...

In the document we provide recommendations for the initial workup, prophylaxis, empiric antibiotic and antifungal therapy, modifications in the empiric regimen and criteria for discontinuing ...

Now, its spent some of that budget on a new antifungal from Scynexis that could tackle an emerging multidrug-resistant (MDR) pathogen. The exclusive licensing deal covers Brexafemme (ibrexafungerp ...

Antifungal agents are substances that inhibit the spread of fungi by killing fungal cells or spores or preventing their growth.

2016; Berman and Krysan, 2020). Antifungal therapy and prophylaxis are key for reducing the mortality and comorbidity associated with fungal infections. However, they are also primary factors driving ...

Agrichemical use of antifungals has created moulds with a propensity to evolve resistance to novel drugs to treat fungal infections, including drugs not on the market yet. The fungus in question, ...

Candidiasis. Studies of all three echinocandins have been conducted to assess their efficacy and toxicity in the treatment of esophageal candidiasis. A dose-response study of 245 patients compared ...